Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00870532
What this trial is testing

Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
National Cancer Centre, Singapore 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314372
What this trial is testing

FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)Hepatocellular Carcinoma (HCC)Liver Cancer Adult
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 86
Large-scale testing (Phase 3)UnknownNCT02748772
What this trial is testing

Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical

Who this might be right for
Colorectal Neoplasms
The First People's Hospital of Hefei 148
Testing effectiveness (Phase 2)Ended earlyNCT00393094
What this trial is testing

Bevacizumab and Irinotecan to Treat Brain Tumors

Who this might be right for
High-Grade Gliomas
National Cancer Institute (NCI) 31
Not applicableNot Yet RecruitingNCT06858956
What this trial is testing

Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer

Who this might be right for
Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)Looking for participantsNCT06360042
What this trial is testing

Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC

Who this might be right for
Unresectable Hepatocellular Carcinoma
Peking University Cancer Hospital & Institute 111
Testing effectiveness (Phase 2)Ended earlyNCT00476827
What this trial is testing

A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain

Who this might be right for
Breast Cancer
Duke University 16
Testing effectiveness (Phase 2)Study completedNCT04172571
What this trial is testing

The Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Akeso 31
Testing effectiveness (Phase 2)Ended earlyNCT01067989
What this trial is testing

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

Who this might be right for
ChemotherapyBreast Cancer, Metastatic
HaEmek Medical Center, Israel 22
Early research (Phase 1)Study completedNCT01260025
What this trial is testing

Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor

Who this might be right for
TolerabilityPharmacokineticsEndostatin
Sun Yat-sen University 20
Testing effectiveness (Phase 2)Study completedNCT01553188
What this trial is testing

AMG 386 and Abiraterone for Advanced Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstate CancerNeoplasm, Prostate+1 more
National Cancer Institute (NCI) 36
Not applicableStudy completedNCT00842790
What this trial is testing

Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging

Who this might be right for
Carcinoma, Renal Cell
Assistance Publique - Hôpitaux de Paris 107
Early research (Phase 1)Study completedNCT01251926
What this trial is testing

EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00016549
What this trial is testing

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT00176748
What this trial is testing

Treatment for Patients With Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer
University of Michigan Rogel Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00076011
What this trial is testing

Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Kidney Neoplasms
Pfizer 52
Testing effectiveness (Phase 2)Study completedNCT00006276
What this trial is testing

Micellar Paclitaxel to Treat Severe Psoriasis

Who this might be right for
Psoriasis
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Ended earlyNCT00923117
What this trial is testing

Sunitinib to Treat Recurrent Brain Cancer

Who this might be right for
Glioblastoma MultiformeMalignant GliomasAnaplastic Gliomas
National Cancer Institute (NCI) 87
Early research (Phase 1)Study completedNCT00006155
What this trial is testing

SU5416 and Carboplatin to Treat Ovarian Cancer

Who this might be right for
Fallopian Tube NeoplasmOvarian CancerPeritoneal Neoplasm
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT00678977
What this trial is testing

A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 22
Next Page